While Chevrolet calibrates the 2025 Silverado's 10-spd transmission for efficiency in 'Normal' mode, a growing number of owners are reporting that the 'Sport' setting actually mitigates the shift-lag ...

General Motors is recalling nearly 12,000 pickup trucks due to a defect that could cause the engine to stall and increase the ...

A vast majority of them are 2025-2026 Chevrolet Silverado 3500 and GMC Sierra 3500 pickups. Impacted models are equipped with ...

Add Yahoo as a preferred source to see more of our stories on Google. The news comes from The Hollywood Reporter which shared that more than 750 shorts will begin rotation on TCM beginning February 2 ...

The beloved “Looney Tunes” franchise has finally found a home at TCM. Beginning in February, the Warner Bros. Discovery-owned cable network will begin airing the animated films as part of a six-year ...

There is no vehicle type more American than the full-size SUV. These truck-based behemoths are the nation’s preferred large family haulers, with no brand more closely tied to the segment than ...

The 2026 Chevrolet Trax Activ is one of the most convincing small crossovers in its price range. It looks good, drives with confidence, and offers real-world practicality and tech without creeping ...

Chevrolet’s focus is much more on SUVs and trucks than cars. Now that the Malibu is gone, the only true car it still builds is the Corvette, which is treated to a major update for 2026. Changes are ...

The TCM Classic Film Festival isn’t just high on vintage films — occasionally, at least, the festival also finds a way to make room for long-gone methods of projection and exhibition. This is, after ...

It’s a family affair this time around, with Ben Mankiewicz examining all that went into the making of the scandalous epic directed by his uncle Joe. By Mike Barnes Senior Editor As TCM notes, the ...

Aging is the primary risk factor for numerous life-threatening diseases and has long been a central focus of biological research. Epigenetic reprogramming, a process that can modulate cell fate and ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months. A ...